NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/11/2024
Back to search
Official data from USPTO
PHARMAZAM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PHARMAZAM
ST13
US500000087492318Class
9, 10, 42
Filing
87492318
Registration
5434802
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
09/11/2024
Classification
Registered
Trademark type
Word
Nice classes
9, 10, 42
Filing date
06/16/2017
Registration date
03/27/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/11/2024
Last transaction
09/11/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/24/2016
First use in commerce
11/24/2016
Drawing code
4
Owner type
16
Owner location
New Port Richey, FL, US
Examiner
CLAYTON, CHERYL A
Current location
FILE DESTROYED
Holders and representatives
Holders
Pharmazam, LLC
Pharmazam, LLC
Representatives
Zachary D. Messa JOHNSON POPE BOKOR RUPPEL & BURNS, LLP
Technical classification
Nice Classes
Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable software for medication management
Class 10
Human DNA testing kits for medical purposes
Class 42
Software as a service featuring software for medication management; Providing temporary use of on-line non-downloadable software for medication management
Publications
History of USPTO decisions and trademark events.
31 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/11/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/11/2024
E815
TEAS SECTION 8 & 15 RECEIVED
02/28/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/27/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/27/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/21/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/20/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/01/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/31/2018
EX1G
SOU EXTENSION 1 GRANTED
01/31/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/31/2018
IUAF
USE AMENDMENT FILED
01/25/2018
EXT1
SOU EXTENSION 1 FILED
01/25/2018
EEXT
SOU TEAS EXTENSION RECEIVED
01/25/2018
EISU
TEAS STATEMENT OF USE RECEIVED
01/25/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/02/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2017
PUBO
PUBLISHED FOR OPPOSITION
11/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2017
ALIE
ASSIGNED TO LIE
10/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/18/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2017
GNRT
NON-FINAL ACTION E-MAILED
09/16/2017
CNRT
NON-FINAL ACTION WRITTEN
09/16/2017
DOCK
ASSIGNED TO EXAMINER
09/16/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/22/2017
NWAP
NEW APPLICATION ENTERED
06/20/2017
Continuous trademark protection
Get notified about every new filing that threatens PHARMAZAM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.